Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash from Investing Activities (2016 - 2025)

Xtant Medical Holdings has reported Cash from Investing Activities over the past 16 years, most recently at $4.7 million for Q3 2025.

  • Quarterly Cash from Investing Activities rose 332.9% to $4.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Sep 2025, up 148.43% year-over-year, with the annual reading at -$3.7 million for FY2024, 84.95% up from the prior year.
  • Cash from Investing Activities was $4.7 million for Q3 2025 at Xtant Medical Holdings, up from -$317000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $4.7 million in Q3 2025 and troughed at -$17.4 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is -$483000.0 (2021), against an average of -$1.5 million.
  • Year-over-year, Cash from Investing Activities tumbled 4355.5% in 2023 and then surged 332.9% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$595000.0 in 2021, then rose by 29.08% to -$422000.0 in 2022, then tumbled by 448.1% to -$2.3 million in 2023, then skyrocketed by 75.49% to -$567000.0 in 2024, then skyrocketed by 925.22% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Cash from Investing Activities are $4.7 million (Q3 2025), -$317000.0 (Q2 2025), and -$1.1 million (Q1 2025).